The presence of IL‐6 in the conditioned media of human colon cancer‐derived mesenchymal stem cells enhances the migration and metastatic capability of CRC cells by upregulating Notch1 and CD44 levels [173]. This evidence concerns the gene IL6 and colorectal carcinoma.